Loading insider details...
Latest Form 4 (Oct 6, 2026): Sale of 13 GLUE shares, $137.28.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Sale | 13 | $137.28 |
| Apr 7, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | Grant/Award | 4,300 | n/a |